Invent

What is Invent?

Invent is a seed capital investment firm based in Rome, Italy with a focus on innovation consulting, business administration, development, and financing of high-tech projects and start-up creation.

The firm operates with a clear investment thesis, targeting early-stage ventures particularly within the sectors of IT & TMT, FinTech & Financial Services, Energy, Retail & E-commerce, CleanTech, and biotechnology, expressing a strong preference for projects with deep tech components across these industries.

With an investment range capped at 160,000 Euros, Invent functions as both an investor and a partner. They actively engage with entrepreneurs who are eager to make significant impacts, bringing forth bright ideas and nurturing them into viable businesses. Since its inception in 2001, Invent has played an integral role as an innovation booster, collaborating with business incubators, public and private entities, angel investors, venture capitalists, and experts in business and technology to support its portfolio companies.

Invent's hands-on approach includes connecting startups with a network that spans Europe and beyond, guiding strategy to assist startups during their formative years, and offering a suite of services tailored to maximize profitability and accelerate growth.

The firm's achievements are highlighted through its successful investments in startups such as MBS, which is innovating in microbial analysis, EXPLORA, with its developments in nucleic acid applications, MEDIAPHARMA, focusing on cancer research, and EUROVIRON, which is creating portable kits for identifying viruses and rare diseases.

Each of these companies exemplifies Invent's belief in the combination of good ideas, personal skills, and appropriate support as the key ingredients for a successful business venture.